S.J. Hayflick

s.j.hayflick umcg.nl


  1. 4 '-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN

    Jeong, S. Y., Hogarth, P., Placzek, A., Gregory, A. M., Fox, R., Zhen, D., Hamada, J., van der Zwaag, M., Lambrechts, R., Jin, H., Nilsen, A., Cobb, J. S., Pham, T., Gray, N., Ralle, M., Du, M., Schwanemann, L., Rai, P., Freed, A., Wakeman, K., Woltjer, R. L., Sibon, O. C. M. & Hayflick, S. J., 29-Oct-2019, In : EMBO Molecular Medicine. 17 p., 10489.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity

    Kosec, G., Podgorsek Berke, A., Petkovic, H., Sibon, O. C. M., Srinivasan, B. & Hayflick, S. J., 21-Dec-2017, Patent No. WO2017218963, Priority date 16-Jun-2016

    Research output: PatentProfessional

  3. Acetyl-4'-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency

    Di Meo, I., Colombelli, C., Srinivasan, B., de Villiers, M., Hamada, J., Jeong, S. Y., Fox, R., Woltjer, R. L., Tepper, P. G., Lahaye, L. L., Rizzetto, E., Harrs, C. H., de Boer, T., van der Zwaag, M., Jenko, B., Čusak, A., Pahor, J., Kosec, G., Grzeschik, N. A., Hayflick, S. J., Tiranti, V. & Sibon, O. C. M., 12-Sep-2017, In : Scientific Reports. 7, 1, 12 p., 11260.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (4) »

ID: 34400032